Business Description
![Zeo ScientifiX Inc Zeo ScientifiX Inc logo](https://static.gurufocus.com/logos/0C0000A8TI.png?14)
Zeo ScientifiX Inc
NAICS : 325412
SIC : 2834
ISIN : US09074L1052
Description
Zeo ScientifiX Inc is a clinical-stage biopharmaceutical company located inside Nova Southeastern University's Collaborative Center for Research in Davie, Florida. It is principally focusing on the development of innovative biological therapeutics for the treatment of chronic diseases and the provision of related services.
Financial Strength
3/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Cash-To-Debt | 1.09 | |||||
Equity-to-Asset | -0.88 | |||||
Debt-to-Equity | -0.4 | |||||
Debt-to-EBITDA | -0.15 | |||||
Piotroski F-Score | 4/9 | |||||
Altman Z-Score | -48.24 | |||||
Beneish M-Score | -14.44 | |||||
WACC vs ROIC |
Growth Rank
1/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | -10.7 | |||||
3-Year EBITDA Growth Rate | 38.4 | |||||
3-Year EPS without NRI Growth Rate | 36.5 | |||||
3-Year FCF Growth Rate | 18.4 | |||||
3-Year Book Growth Rate | 16.9 |
Momentum Rank
4/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
5-Day RSI | 62.12 | |||||
9-Day RSI | 57.07 | |||||
14-Day RSI | 54.48 | |||||
6-1 Month Momentum % | -33.61 | |||||
12-1 Month Momentum % | -43.68 |
Liquidity Ratio
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Current Ratio | 0.39 | |||||
Quick Ratio | 0.32 | |||||
Cash Ratio | 0.21 | |||||
Days Inventory | 139.18 | |||||
Days Sales Outstanding | 2.8 |
Dividend & Buy Back
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Average Share Buyback Ratio | -15.7 | |||||
Shareholder Yield % | 0.99 |
Profitability Rank
2/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Gross Margin % | 85 | |||||
Operating Margin % | -109.66 | |||||
Net Margin % | -104.46 | |||||
FCF Margin % | -25.24 | |||||
ROA % | -198.96 | |||||
ROIC % | -273.12 | |||||
ROC (Joel Greenblatt) % | -562.54 |
GF Value Rank
10/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
PS Ratio | 2.67 | |||||
EV-to-EBIT | -2.84 | |||||
EV-to-EBITDA | -2.97 | |||||
EV-to-Revenue | 2.79 | |||||
EV-to-FCF | -11.06 | |||||
Earnings Yield (Greenblatt) % | -35.21 | |||||
FCF Yield % | -9.55 |